Dr. Kraus is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8300 Floyd Curl Drive
4th Floor -4B
San Antonio, TX 78229Phone+1 210-450-9600Fax+1 210-450-9656
Education & Training
- University of Texas San AntonioMBA, Business Administration with Healthcare focus, 2018 - 2020
- Rutgers Health/Robert Wood Johnson Medical SchoolResidency, Urology, 1993 - 1997
- Rutgers Health/Robert Wood Johnson Medical SchoolResidency, Surgery, 1991 - 1993
- Rutgers Robert Wood Johnson Medical SchoolClass of 1991
Certifications & Licensure
- TX State Medical License 2002 - 2026
- NJ State Medical License 1993 - 2003
- American Board of Urology Urology
- American Board of Urology Female Pelvic Medicine and Reconstructive Surgery
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Fellow (FACS) American College of Surgeons
Clinical Trials
- Combined Behavioral and Drug Treatment of Overactive Bladder in Men Start of enrollment: 2010 Jul 01
Publications & Presentations
PubMed
- 122 citationsThe sensitivity and specificity of a simple test to distinguish between urge and stress urinary incontinence.Jeanette S. Brown, Catherine S. Bradley, Leslee L. Subak, Holly E. Richter, Stephen R. Kraus
Annals of Internal Medicine. 2006-05-16 - 92 citationsEffect of Fesoterodine in Vulnerable Elderly Subjects with Urgency Incontinence: A Double-Blind, Placebo Controlled TrialCatherine E. DuBeau, Stephen R. Kraus, Tomas L. Griebling, Diane K. Newman, Jean F. Wyman
The Journal of Urology. 2014-02-01 - 18 citationsEfficacy and tolerability of fesoterodine versus tolterodine in older and younger subjects with overactive bladder: a post hoc, pooled analysis from two placebo-contro...Catherine E. DuBeau, Jon D. Morrow, Stephen R. Kraus, Dana Creanga, Tamara Bavendam
Neurourology and Urodynamics. 2012-08-20
Journal Articles
- Considering the Effect of Combining Α-blockers with Bladder Antimuscarinics in Treatment of Overactive Bladder Symptoms—ReplyStephen Kraus, MD, JAMA Internal Medicine
Press Mentions
- San Antonio’s Top Doctors 2023January 1st, 2023
- SUFU 2020: Treatment Patterns and Costs Among Patients with Overactive Bladder Receiving Combination Oral Therapy, Sacral Nerve Stimulation, Percutaneous Tibial Nerve Stimulation or OnabotulinumtoxinAFebruary 29th, 2020
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: